Keytruda Alone Bests Chemo in Advanced NSCLC

(MedPage Today) -- Monotherapy boosts survival in patients with low PD-L1, no EGFR or ALK alterations
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news